Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase

NCT00027144

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: University of Connecticut Health Center Farmington, Connecticut, United States

View Trial Details

Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

NCT00002126

Conditions: Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations: Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham, Alabama, United States

Maricopa County Med Ctr Phoenix, Arizona, United States

CARE Ctr / UCLA Med Ctr Los Angeles, California, United States

UCSF - San Francisco Gen Hosp San Francisco, California, United States

View all 22 locations

View Trial Details

Completed

The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT

NCT00002302

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: AIDS Research Consortium of Atlanta Atlanta, Georgia, United States

Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

NCT00002263

Conditions: Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations: Natl Cancer Institute / HIV / AIDS Malignancy Branch Bethesda, Maryland, United States

View Trial Details

Completed

Treatment Program for Anemia in AIDS Patients

NCT00002022

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: R W Johnson Pharmaceutical Research Institute Raritan, New Jersey, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia

NCT00002042

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anemia, +19 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

NCT00002250

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +29 more
Locations: San Francisco Gen Hosp San Francisco, California, United States

View Trial Details

Completed

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

NCT00002070

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Agranulocytosis, +39 more
Locations: USC School of Medicine / Norris Cancer Hosp Los Angeles, California, United States

UCLA CARE Ctr Los Angeles, California, United States

Children's Hosp of San Francisco San Francisco, California, United States

Pacific Presbyterian San Francisco, California, United States

View all 14 locations

View Trial Details

Completed

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

NCT00002006

Conditions: Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations: Natl Cancer Institute Bethesda, Maryland, United States

View Trial Details

Completed

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

NCT00050843

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Scripps Cancer Center La Jolla, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

Desert Hematology Oncology Medical Group INC Rancho Mirage, California, United States

Whittingham Cancer Center Norwalk, Connecticut, United States

View all 38 locations

View Trial Details